Advanced AI-Powered Analysis
aview LCS Plus is an innovative solution with advanced AI designed to identify and analyze major chest diseases.
It is characterized by the detection of small lung nodules that can potentially lead to lung cancer, the assessment of damage to the lung parenchyma and the identification of coronary artery calcification.
As this diagnostic tool offers the possibility of detecting and analyzing several breast diseases simultaneously, it is very effective both for initial screening and for ongoing follow-up care.
Key Components
LCS Plus consists of three solutions:
1. Chronic Obstructive Pulmonary Disease (COPD): It is able to detect and treat COPD cases.
2. Lung Cancer Screening (LCS): Plays a crucial role in the early detection of lung cancer.
3. Coronary Artery Calcium Scoring (CAC): It is used for assessing calcium scoring in coronary arteries, an important indicator of heart disease risk.
Automated Detection and Analysis Solution for Lung Nodules, COPD, CAC
Each of these is targeted at specific diseases and can be used as a stand-alone product. This versatility makes it a highly efficient tool for different diagnostic requirements.
Detailed Analysis Capabilities
Emphysema Analysis:
The system interprets low-dose chest CT images to analyze and report on emphysema, offering comprehensive and automated reporting.
Lung Nodules Detection and Analysis:
It also processes low-dose chest CT images to detect and analyze lung nodules, providing automated reporting for efficient diagnosis.
Detection of Calcium in Coronary Artery:
It efficiently identifies calcification in coronary arteries using low-dose chest CT images and automatically reports the findings.
Global Lung Cancer Screening Initiatives
LCS Plus is a trusted solution in global lung cancer screening projects.
K-Lucas
-
Primary AI solution in South Korea's K-Lucas project
-
Serving as the sole AI provider for seven consecutive years
-
Screening 200,000 high-risk individuals annually
-
Comprehensive Cloud-based Quality Management Service
HANSE
-
In Germany's HANSE project, it's used in three hospitals across two states
-
Hannover Medical School
-
University Medical Center Schleswig-Holstein
-
LungenClinic Grosshansdorf
-
Two-Year Lung Cancer Screening for 5,000 Individuals
ILSP
-
The ILSP project in Italy involves 18 hospitals in 18 states.
-
Two-Year Lung Cancer Screening for 5,000 Individuals
4-In-The-Lung-Run
-
The 4-In-The-Lung-Run project spans five European countries
-
the Netherlands, Germany, Spain, Italy, and France
-
Screening 26,000 individuals over four years.
